Drug repositioning is a dynamic strategy that identifies new therapeutic applications for existing medications. This approach maximizes the drug lifecycle while reducing time-to-market compared to developing new treatments.
In the evolving healthcare landscape, particularly in the bio-pharma sector, patient support programs (PSPs) play a critical role in improving patient outcomes.
In the pharmaceutical and biotech industries, securing market access and favorable reimbursement decisions is crucial for a product’s success. Scientific promotion has emerged as a key strategy for navigating the